JAK1 signaling in dendritic cells promotes peripheral tolerance in autoimmunity through PD-L1-mediated regulatory T cell induction

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/35196494

Research summary

This study investigates the role of Janus kinase 1 (JAK1) signaling within dendritic cells (DCs) in maintaining peripheral immune tolerance. Using a mouse model with DC-specific deletion of JAK1, researchers observed exacerbated experimental autoimmune encephalomyelitis (EAE), characterized by increased CD4+ T cell proliferation and reduced regulatory T cell (Treg) induction. The findings highlight the importance of JAK1-STAT1 signaling in DCs for upregulating PD-L1 expression, which is crucial for the conversion of naive CD4+ T cells into Tregs and the suppression of autoimmune responses.

Key outcome of the study

JAK1 signaling in DCs is essential for PD-L1 expression and the induction of Tregs, thereby promoting peripheral tolerance and mitigating autoimmune pathology in EAE.

Mouse model

DC-specific JAK1 Knockout mouse model, generated by crossing Jak1^flox/flox mice with CD11c-Cre transgenic mice to achieve targeted deletion of JAK1 in dendritic cells.

TARGET:
JAK1
Janus kinase 1

Keywords

Autoimmunity, Peripheral tolerance, Dendritic cells, Regulatory T cells, PD-L1, JAK-STAT signaling

Technical specifications

Conditional Knockout model, CD11c-Cre, Jak1^flox/flox, Dendritic cell-specific gene deletion

Related products

Catalogue product

KO repository

>2000 conditional Knockout mouse models for target discovery and  confirmation, in vivo compound specificity, MOA, and clinical studies

Customized product

No items found.